PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 172 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $486,125 | -57.2% | 15,845 | -43.1% | 0.01% | -61.3% |
| Q1 2023 | $1,137,089 | -30.0% | 27,863 | -33.7% | 0.03% | -32.6% |
| Q4 2022 | $1,623,357 | +496.8% | 42,045 | +801.9% | 0.05% | +283.3% |
| Q2 2022 | $272,000 | +32.7% | 4,662 | +2.8% | 0.01% | 0.0% |
| Q4 2019 | $205,000 | -82.9% | 4,533 | -83.5% | 0.01% | -88.9% |
| Q2 2019 | $1,196,000 | +133.1% | 27,502 | +104.2% | 0.11% | +200.0% |
| Q1 2019 | $513,000 | -53.2% | 13,467 | -47.2% | 0.04% | -47.8% |
| Q4 2018 | $1,097,000 | +116.4% | 25,496 | +146.9% | 0.07% | +81.6% |
| Q3 2018 | $507,000 | -61.2% | 10,325 | -74.7% | 0.04% | -58.2% |
| Q2 2018 | $1,307,000 | +101.1% | 40,765 | +186.2% | 0.09% | +28.2% |
| Q4 2017 | $650,000 | +209.5% | 14,246 | +155.1% | 0.07% | +34.0% |
| Q3 2017 | $210,000 | -10.3% | 5,584 | +14.0% | 0.05% | -17.2% |
| Q2 2017 | $234,000 | -1.3% | 4,900 | -5.8% | 0.06% | +113.3% |
| Q1 2017 | $237,000 | -66.7% | 5,200 | -75.0% | 0.03% | -81.1% |
| Q3 2016 | $712,000 | -29.1% | 20,800 | +84.1% | 0.16% | +55.9% |
| Q1 2015 | $1,004,000 | – | 11,300 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |